WinstonWınston
Terveystalo Oyj logo

Terveystalo Oyj

TTALO.HE
57
Medical - Care Facilities · Healthcare
Price
€7.61
+0.05 (+0.66%)
Market Cap
€965.0M
Exchange
NASDAQ Helsinki
Winston Score
57
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Aug 9, 2026 · filings through Jun 30, 2026

Terveystalo is Finland's largest private healthcare company. It runs a network of clinics and hospitals across Finland where people can see doctors, get lab tests, have surgeries, and receive mental health care. Its main customers are private individuals, employers who pay for employee healthcare, and insurance companies.

The company earns money by charging fees for medical visits and procedures, and through corporate contracts where businesses pay for their employees' occupational health services. Terveystalo operates almost entirely in Finland, with some presence in Sweden, and generates roughly €1 billion in annual revenue. Its large clinic network and strong employer relationships give it a scale advantage that is hard for smaller rivals to match. The key growth driver is rising demand for private healthcare in Finland, where public sector waiting times remain long — but the main risk is pressure on pricing from large corporate clients and potential regulatory changes to Finland's healthcare funding system.

Winston Score History

Share count broadly stable

0.7% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 127.7M (2021) → 126.8M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
58.8%
Premium pricing power — 58.8% gross margin
Operating Margin
7.9%
Modest — 7.9% operating margin
ROCE
2.3%
Weak — 2.3% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-8.1%
Shrinking sales (-8.1% YoY)
EPS YoY
-23.9%
Earnings shrinking (-23.9% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
6/8 quarters
Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
242%
Turns 242% of profit into real cash
FCF Margin
10.7%
Modest free cash flow (10.7%)

FCF margin between 10% and 20%. Every $100 in sales becomes $10 to $20 in real cash.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.85
Moderate — manageable debt (0.85)
Interest Cover
4.79x
Adequate interest coverage (4.8x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
14.1x
Attractive valuation — P/E 14.1

P/E in the normal range. Price is roughly $15 for every $1 of yearly profit.

P/E vs Forward
+4.6
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (14.1 → 9.5)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
7.40%
Healthy income — 7.40% yield

Yield above 6% — often a flag the market is pricing in a cut.

Dividend Growth
+93.1%
Dividend growing fast (93.1% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial